BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24789960)

  • 1. Doxycycline in lymphangioleiomyomatosis: not all questions are answered.
    Johnson SR; Chang WY; Tattersfield AE; Lewis S; Kumaran M; Cane JL
    Eur Respir J; 2014 May; 43(5):1538. PubMed ID: 24789960
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxycycline in lymphangioleiomyomatosis: not all questions are answered.
    Baldi BG; Ribeiro Carvalho CR
    Eur Respir J; 2014 May; 43(5):1536-7. PubMed ID: 24789959
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.
    Moses MA; Harper J; Folkman J
    N Engl J Med; 2006 Jun; 354(24):2621-2. PubMed ID: 16775248
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases.
    Cottin V
    Eur Respir J; 2014 Apr; 43(4):966-9. PubMed ID: 24687668
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphangioleiomyomatosis.
    Fernández-Fernández FJ; Buño-Ramilo B; Sesma P
    Eur J Intern Med; 2009 Jan; 20(1):e24. PubMed ID: 19237077
    [No Abstract]   [Full Text] [Related]  

  • 6. The way forward in lymphangioleiomyomatosis: a trial for every patient, every patient in a trial.
    McCormack FX
    J Bras Pneumol; 2011; 37(4):422-3. PubMed ID: 21881730
    [No Abstract]   [Full Text] [Related]  

  • 7. A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis.
    Chang WY; Cane JL; Kumaran M; Lewis S; Tattersfield AE; Johnson SR
    Eur Respir J; 2014 Apr; 43(4):1114-23. PubMed ID: 24311763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphangioleiomyomatosis: new therapeutic approaches].
    Casanova A; Ancochea J
    Arch Bronconeumol; 2011 Dec; 47(12):579-80. PubMed ID: 21924539
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase.
    Ng HY; Oliver BG; Burgess JK; Krymskaya VP; Black JL; Moir LM
    J Cell Mol Med; 2015 Nov; 19(11):2633-46. PubMed ID: 26282580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of lymphangioleiomyomatosis.
    Taillé C; Borie R; Crestani B
    Curr Opin Pulm Med; 2011 Sep; 17(5):374-8. PubMed ID: 21760507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre.
    Baldi BG; Freitas CS; Araujo MS; Dias OM; Pereira DA; Pimenta SP; Kairalla RA; Carvalho CR
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):129-35. PubMed ID: 25078640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangioleiomyomatosis: New Treatment Perspectives.
    Radzikowska E
    Lung; 2015 Aug; 193(4):467-75. PubMed ID: 25980593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.
    El-Chemaly S; Henske EP
    Expert Rev Respir Med; 2015 Apr; 9(2):195-204. PubMed ID: 25757365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphangioleiomyomatosis: an orphan disease in search for treatment].
    Aruj PK
    Medicina (B Aires); 2011; 71(4):402-4. PubMed ID: 21893460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymphangioleiomyomatosis and translational medicine].
    Barcat JA
    Medicina (B Aires); 2007; 67(5):514-6. PubMed ID: 18051238
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone-releasing hormone analogues.
    de la Fuente J; Páramo C; Román F; Pérez R; Masa C; de Letona JM
    Eur J Med; 1993; 2(6):377-8. PubMed ID: 8252188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphangioleiomyomatosis a rare disease in a young women].
    Lommi J; Sirén J; Laine T; Purhonen M; Jeskaner L; Härkönen M
    Duodecim; 1997; 113(2):149-52. PubMed ID: 11370045
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic sirolimus therapy for lymphangioleiomyomatosis.
    McCormack FX
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1332-3. PubMed ID: 25496098
    [No Abstract]   [Full Text] [Related]  

  • 19. High dose progesterone therapy in lymphangioleiomyomatosis: a case report and review of literature.
    Ho AY; Lam B; Ooi CC; Tan KC; Tsang KW
    Chin Med J (Engl); 1998 Aug; 111(8):759-61. PubMed ID: 11245037
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberous sclerosis complex and lymphangioleiomyomatosis: miles to go, promises to keep.
    Henske E
    Ann Intern Med; 2011 Jun; 154(12):840-1. PubMed ID: 21690600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.